Back to search

National and Kapodistrian University of Athens

Διερεύνηση των μηχανισμών που εμπλέκονται στην παθογένεια των Τ δερματικών λεμφωμάτων και των υποψήφιων φαρμάκων, με τη χρήση μοριακών τεχνικών και βιοπληροφορικής ανάλυσης με σκοπό τη βελτίωση της πρόγνωσης, της διάγνωσης και της θεραπείας

Abstract

dc:description

Cutaneous T-cell lymphomas (CTCL) represent a heterogeneous group of extranodal non-Hodgkin lymphomas, originating from malignant clonal mature T lymphocytes that infiltrate the skin. The pathogenesis of Mycosis fungoides (MF) and Sézary syndrome (SS) remains poorly understood, while their early diagnosis is challenging since their clinical presentation shares key similarities with inflammatory skin diseases. Identifying biomarkers for the early diagnosis of the disease has become a priority today. In addition, the resistance of CTCL to chemotherapy requires further investigation and necessitates the development of new targeted therapies. The discovery of new drugs is a time-consuming and costly process that does not always lead to the desired outcome. A large number of drug candidates entering clinical trials are deemed ineffective in phases I or II and thus never reach the market. As a result, in recent years, pharmaceutical companies have shifted away from investing in drug discovery and instead focused on drug repurposing. The identification through bioinformatics of the genetic signature of cutaneous T-cell lymphomas (disease signature) and its correlation with drug signatures offers a simple and cost-effective way to assign new indications to already existing drugs (drug repurposing). In the present doctoral dissertation, through the use of bioinformatics tools as well as molecular analysis, the aim was to investigate the mechanisms involved in the pathogenesis of cutaneous T-cell lymphomas, to identify new therapeutic strategies (by repurposing existing drugs), and to discover biomarkers for the improved and less invasive diagnosis of CTCL. Specifically, using bioinformatics analysis, we highlighted differentially expressed genes and miRNAs in CTCL, as well as pathways implicated in the disease’s pathogenesis. Subsequently, using computational tools, we selected a subset of miRNAs (miR-26a, miR-92a, miR-106b, miR-142, miR-146a, miR-155, miR-181a, miR-222, and miR-494) and measured their expression in biopsies, cells, and patient blood samples. All miRNAs were found to be overexpressed in CTCL patients compared to control groups. In all CTCL patients, elevated levels of miR-146a, miR-142, and miR-155 were detected compared to each control group and the healthy cohort, suggesting that these could serve as promising biomarkers. Furthermore, when we used inhibitors of miR-142, miR-146a, and miR-155 to downregulate their expression in CTCL cell lines, a reduction in malignant cell proliferation and induction of apoptosis was observed. This implies a potential therapeutic role of these miRNAs. Finally, through bioinformatics and specifically drug repurposing approaches, we identified three lists of pharmaceutical agents that could, after further study, be used as treatments for CTCL.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Papadaki, Marianna
  • Παπαδάκη, Μαριάννα

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61278

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Papadaki, Marianna; Παπαδάκη, Μαριάννα. Διερεύνηση των μηχανισμών που εμπλέκονται στην παθογένεια των Τ δερματικών λεμφωμάτων και των υποψήφιων φαρμάκων, με τη χρήση μοριακών τεχνικών και βιοπληροφορικής ανάλυσης με σκοπό τη βελτίωση της πρόγνωσης, της διάγνωσης και της θεραπείας. National and Kapodistrian University of Athens, 2026. http://hdl.handle.net/10442/hedi/61278